Literature DB >> 6413482

Synergy of azlocillin with aminoglycosides.

N X Chin, H C Neu.   

Abstract

The combination of azlocillin and the aminoglycosides amikacin, gentamicin, netilmicin, sisomicin, and tobramycin was synergistic. The FIC index was less than or equal to 0.5 for 28 to 42% of Pseudomonas aeruginosa isolates tested and with an additive FIC index greater than 0.5-1 for 53 to 63% of the isolates. Antagonism was not encountered. Isolates resistant to azlocillin (MIC greater than 100 mg/l) were more often synergistically inhibited by the combination of azlocillin and an aminoglycoside. The concentrations of antibiotics that synergistically inhibited Pseudomonas were those readily achieved in man. The combination of azlocillin and aminoglycosides prevented regrowth of isolates that grew after initial suppression by the antibiotics alone.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6413482     DOI: 10.1093/jac/11.suppl_b.33

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics.

Authors:  J G den Hollander; J W Mouton; H A Verbrugh
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.

Authors:  J G den Hollander; A M Horrevorts; M L van Goor; H A Verbrugh; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

3.  Time-survival studies for quantifying effects of azlocillin and tobramycin on Pseudomonas aeruginosa.

Authors:  M M McFarland; E M Scott; A Li Wan Po
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 4.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.